Trial
NCT05549323
A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Ulcerative Colitis
Intervention
PF-07054894
Why stopped
The study was terminated due to business decision. The decision to terminate the trial was not based on any safety concerns associated with PF-07054894.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-25